Nephrogenic diabetes insipidus: clinical and pathophysiological aspects.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D000242:Cyclic AMP / Q000378:metabolism; D003919:Diabetes Insipidus / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D015232:Dinoprostone; D005260:Female; D005808:Genes, Recessive; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007684:Kidney Tubules / Q000503:physiopathology*; D007685:Kidney Tubules, Collecting / Q000503:physiopathology*; D008297:Male; D011458:Prostaglandins E / Q000502:physiology; D012964:Sodium / Q000008:administration & dosage; D014667:Vasopressins / Q000502:physiology*
D011458:Prostaglandins E; D006852:Hydrochlorothiazide; D014667:Vasopressins; D012964:Sodium; D000242:Cyclic AMP; D015232:Dinoprostone; D007213:Indomethacin